Építés alatt – nem éles oldal
Belépés

NCT06038630Toboroz2. fázis

129Xe MRI Cardiopulmonary

129Xe Gas Exchange MRI to Visualize Cardiopulmonary Function

Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. febr. 4.

Következő lépések

Rövid összefoglaló (regiszter, angolul)

The goal of this NIH-sponsored study is to characterize three biomarkers derived from 129Xe gas exchange MRI and to understand how they change in response to interventions.

Állapot (regiszter)
Toboroz
Fázis (regiszter)
2. fázis
Vizsgálattípus
Beavatkozással járó
Résztvevők száma
125 (tervezett)
Első benyújtás
2023. szept. 8.
Kezdés
2024. jan. 12.
Elsődleges befejezés
2028. jún. 30.
Fő szponzor
Bastiaan Driehuys
NCT-szám
NCT06038630

Mit vállalsz

  • Vizsgálat típusa: Beavatkozással járó · 2. fázis
  • Tervezett résztvevők: 125
  • 2024. jan. 12. és az elsődleges befejezés (2028. jún. 30.) között
  • 1 helyszín, 1 országban
  • Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket

A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.

Ki nem vehet részt

Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

Más betegség

  • Respiratory illness of a bacterial or viral etiology within 30 days of MRI
  • Subject has history of any known ventricular cardiac arrhythmia
  • Subject has history of cardiac arrest within the last year
  • Medical or psychological conditions which, in the opinion of the investigator, might create undue risk to the subject or interfere with the subject's ability to comply with the protocol requirements

Egyéb

  • Subjects presenting with any of the following will not be included in the trial:
  • MRI is contraindicated based on responses to MRI screening questionnaire
  • Subject is pregnant or lactating
  • Resting O2 saturation <90% with maximum supplemental O2 delivered by nasal canula
  • Subject does not fit into 129Xe vest coil used for MRI
  • Subject cannot hold his/her breath for 10 seconds
  • Subject deemed unlikely to be able to comply with instructions during imaging

Kiket keres a vizsgálat

  • (Inclusion Criteria: Subjects must meet all of the following inclusion criteria to be eligible for enrollment into the trial)
  • Outpatients of either gender, age > 18
  • Willing and able to give informed consent and adhere to visit/protocol (Consent must be given before any study procedures are performed.)
  • Subject has no diagnosed pulmonary conditions
  • Subject has not smoked in the previous 5 years
  • Smoking history, if any, is less than or equal to 5 pack-years
  • No history of using other inhaled products more than 1/week for > 1 year
  • In-patient or outpatients of either sex, age > 18
  • Willing and able to give informed consent and adhere to visit/protocol
    • And one of the following:
  • Patients who are scheduled to receive a red cell transfusion for anemia.
  • Patients who are scheduled to undergo therapeutic phlebotomy to treat erythrocytosis or polycythemia
  • Healthy volunteers undergoing voluntary whole blood donation (healthy volunteer inclusion criteria noted above)
  • In-patient or outpatients of either sex, age > 18
  • Willing and able to give informed consent and adhere to visit/protocol
    • And one of the following categories (ILD, Dyspnea, CTEPH, or Healthy):
  • Interstitial Lung Disease or Dyspnea
    • Physician diagnosis of Interstitial Lung Disease by a pulmonologist using established criteria or physician referral of patient with dyspnea
    • OR
  • Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
    • Patients with a diagnosis of CTEPH, defined as mean PA pressure >20 mmHg with a pulmonary vascular resistance >2 WU and pulmonary capillary wedge pressure ≤15 mmHg at right heart catheterization with evidence of chronic thromboembolic disease on clinical imaging after 3 months of anticoagulation
    • Scheduled for pulmonary thromboendoarterectomy (PTE) surgery and willing to re-turn 3-6 months after for optional follow-up scans
    • OR
  • Healthy Volunteer (criteria noted above)
  • In-patient or outpatients of either sex, age > 18
  • Willing and able to give informed consent and adhere to visit/protocol
    • And one of the following categories (Acute or Chronic)
  • Acute Pulmonary Embolism
    • Patients presenting with acute PE 24-48hrs post-admission
    • Willing to return after 3-6 months of anti-coagulation therapy
    • OR
  • Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
    • Patients with a diagnosis of CTEPH, defined as mean PA pressure >20 mmHg with a pulmonary vascular resistance >2 WU and pulmonary capillary wedge pressure ≤15 mmHg at right heart catheterization with evidence of chronic thromboembolic disease on clinical imaging after 3 months of anticoagulation
    • Scheduled for pulmonary thromboendoarterectomy (PTE) surgery and willing to re-turn 3-6 months after for optional follow-up scans

Életkor a regiszterben: 18 év – - · Nem: nők és férfiak · Egészséges önkénteseket is fogad

A teljes feltétellista: ClinicalTrials.gov

Helyszínek (1)

Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.

HelyszínVárosOrszágHelyszín állapota
Duke University Medical CenterDurhamEgyesült ÁllamokToboroz

Te vagy a koordinátor? Erősítsd meg az adatokat

Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.